Paul Tudor Jones's SANA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 133,183 shares of Sana Biotechnology, Inc. (SANA) worth $383,567, representing 0.00% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 7 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in SANA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 133,183 shares. Largest reduction occurred in Q3 2025, reducing 111,311 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Sana Biotechnology (SANA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sana Biotechnology (SANA) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +133,183 | New Buy | 133,183 | $2.88 |
| Q3 2025 | -111,311 | Sold Out | 0 | $0.00 |
| Q2 2025 | +111,311 | New Buy | 111,311 | $2.73 |
| Q3 2024 | -51,974 | Sold Out | 0 | $0.00 |
| Q2 2024 | +51,974 | New Buy | 51,974 | $5.46 |
| Q4 2023 | -97,240 | Sold Out | 0 | $0.00 |
| Q3 2023 | +97,240 | New Buy | 97,240 | $3.87 |
Paul Tudor Jones's Sana Biotechnology Investment FAQs
Paul Tudor Jones first purchased Sana Biotechnology, Inc. (SANA) in Q3 2023, acquiring 97,240 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Sana Biotechnology, Inc. (SANA) for 7 quarters since Q3 2023.
Paul Tudor Jones's largest addition to Sana Biotechnology, Inc. (SANA) was in Q1 2026, adding 133,183 shares worth $383,567.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 133,183 shares of Sana Biotechnology, Inc. (SANA), valued at approximately $383,567.
As of the Q1 2026 filing, Sana Biotechnology, Inc. (SANA) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Sana Biotechnology, Inc. (SANA) was 133,183 shares, as reported at the end of Q1 2026.